These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 28164533)
1. Possibility of Coagulation System Activation Determination with Tissue Factor in Pregnancy Complications. Slavik L; Novak M; Ulehlova J; Prochazka M; Prochazkova J; Lattova V; Polak P; Pilka R Clin Lab; 2016 Oct; 62(10):1851-1856. PubMed ID: 28164533 [TBL] [Abstract][Full Text] [Related]
2. Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death. Erez O; Gotsch F; Mazaki-Tovi S; Vaisbuch E; Kusanovic JP; Kim CJ; Chaiworapongsa T; Hoppensteadt D; Fareed J; Than NG; Nhan-Chang CL; Yeo L; Pacora P; Mazor M; Hassan SS; Mittal P; Romero R J Matern Fetal Neonatal Med; 2009 Aug; 22(8):672-87. PubMed ID: 19736615 [TBL] [Abstract][Full Text] [Related]
3. The role of tissue factor in normal pregnancy and in the development of preeclampsia: A review. Prochazkova J; Slavik L; Ulehlova J; Prochazka M Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):192-6. PubMed ID: 25559093 [TBL] [Abstract][Full Text] [Related]
4. Novel considerations in the pathogenesis of the antiphospholipid syndrome: involvement of the tissue factor pathway of blood coagulation. Adams M Semin Thromb Hemost; 2008 Apr; 34(3):251-5. PubMed ID: 18720304 [TBL] [Abstract][Full Text] [Related]
5. Tissue factor in the antiphospholipid syndrome. Kinev AV; Roubey RA Lupus; 2008 Oct; 17(10):952-8. PubMed ID: 18827061 [TBL] [Abstract][Full Text] [Related]
6. Differential expression of protease-activated receptors in monocytes from patients with primary antiphospholipid syndrome. López-Pedrera C; Aguirre MA; Buendía P; Barbarroja N; Ruiz-Limón P; Collantes-Estevez E; Velasco F; Khamashta M; Cuadrado MJ Arthritis Rheum; 2010 Mar; 62(3):869-77. PubMed ID: 20131237 [TBL] [Abstract][Full Text] [Related]
7. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Amengual O; Atsumi T; Khamashta MA; Hughes GR Thromb Haemost; 1998 Feb; 79(2):276-81. PubMed ID: 9493575 [TBL] [Abstract][Full Text] [Related]
8. Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds. Hattori T; Khan MM; Colman RW; Edmunds LH J Am Coll Cardiol; 2005 Aug; 46(4):707-13. PubMed ID: 16098440 [TBL] [Abstract][Full Text] [Related]
9. Enhanced coagulation activation in preeclampsia: the role of APC resistance, microparticles and other plasma constituents. VanWijk MJ; Boer K; Berckmans RJ; Meijers JC; van der Post JA; Sturk A; VanBavel E; Nieuwland R Thromb Haemost; 2002 Sep; 88(3):415-20. PubMed ID: 12353069 [TBL] [Abstract][Full Text] [Related]
10. Role of tissue factor in pregnancy complications: crosstalk between coagulation and inflammation. Girardi G Thromb Res; 2011 Feb; 127 Suppl 3():S43-6. PubMed ID: 21262438 [TBL] [Abstract][Full Text] [Related]
11. Coagulation and fibrinolysis in amniotic fluid: physiology and observations on amniotic fluid embolism, preterm fetal membrane rupture, and pre-eclampsia. Uszyński M; Uszyński W Semin Thromb Hemost; 2011 Mar; 37(2):165-74. PubMed ID: 21370219 [TBL] [Abstract][Full Text] [Related]
12. Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappaB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway. López-Pedrera C; Buendía P; Cuadrado MJ; Siendones E; Aguirre MA; Barbarroja N; Montiel-Duarte C; Torres A; Khamashta M; Velasco F Arthritis Rheum; 2006 Jan; 54(1):301-11. PubMed ID: 16385547 [TBL] [Abstract][Full Text] [Related]
13. Antagonism by IL-4 and IL-10 of endotoxin-induced tissue factor activation in monocytic THP-1 cells: activating role of CD14 ligation. Chu AJ; Prasad JK J Surg Res; 1998 Nov; 80(1):80-7. PubMed ID: 9790819 [TBL] [Abstract][Full Text] [Related]
14. Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction. Steppich B; Mattisek C; Sobczyk D; Kastrati A; Schömig A; Ott I Thromb Haemost; 2005 Jan; 93(1):35-9. PubMed ID: 15630488 [TBL] [Abstract][Full Text] [Related]
15. Clot lysis time and thrombin activatable fibrinolysis inhibitor in severe preeclampsia with or without associated antiphospholipid antibodies. Martínez-Zamora MA; Tassies D; Carmona F; Espinosa G; Cervera R; Reverter JC; Balasch J J Reprod Immunol; 2010 Nov; 86(2):133-40. PubMed ID: 20594598 [TBL] [Abstract][Full Text] [Related]